三类医疗器械
Search documents
欧普康视:公司的主要产品是三类医疗器械
Zheng Quan Ri Bao· 2026-02-13 12:13
Group 1 - The company, Opcon Vision, acknowledged awareness of the Spring Festival Gala's Hefei sub-venue during an interaction with investors [2] - The main products of the company are classified as Class III medical devices, which are subject to strict advertising regulations [2] - Currently, the company promotes its products primarily through professional academic channels and is exploring self-media promotion, but has no plans to participate in the Spring Festival Gala's advertising [2]
达安基因:历来披露全资及控股子公司获得三类医疗器械注册证的情况
Zheng Quan Ri Bao Zhi Sheng· 2026-01-14 10:08
Group 1 - The company disclosed that it has a history of reporting the acquisition of Class III medical device registration certificates by its wholly-owned and controlled subsidiaries [1] - Guangzhou Saiyun Biotechnology Co., Ltd. is a joint venture of the company's controlled subsidiary, Guangzhou Darui Biotechnology Co., Ltd., and is not included in the company's consolidated financial statements [1]
亦庄5年再造一个亦庄
Xin Lang Cai Jing· 2026-01-07 22:24
Core Insights - Beijing Economic Development Zone (经开区) has achieved an average annual GDP growth of 10% during the 14th Five-Year Plan period, with economic output surpassing two trillion yuan, equivalent to creating another Yizhuang [1][2] - The region has developed six trillion-yuan industrial clusters, including integrated circuits, artificial intelligence, and biotechnology, contributing significantly to the local economy [1][3] Economic Performance - The economic total of Beijing Economic Development Zone has maintained an average annual growth rate of 10%, ranking first among national economic development zones [2] - Fixed asset investment has remained above one trillion yuan for three consecutive years, with actual foreign investment among the top in the city [2] - By 2025, the GDP is expected to grow by approximately 9%, and industrial output is projected to increase by around 11%, contributing over 50% to the city's overall growth [2] Innovation and Technology - Over 1,000 technology achievements from the "Three Cities" initiative have been implemented, with a focus on integrated circuit education and industry collaboration [3] - The region has invested heavily in innovation, with R&D intensity exceeding 7% among large-scale enterprises, leading to over 1,000 technology breakthroughs [3] - By 2025, the number of first-time product certifications is expected to rank first in the city, with over 400 provincial-level R&D institutions established [3] Industrial Development - The region aims to achieve an industrial output value exceeding one trillion yuan, supported by policies that enhance efficiency and resource allocation [4] - The "no disturbance" policy has benefited over 23,000 enterprises, with a high percentage of policies being automatically enjoyed by businesses [4] - By the end of the 14th Five-Year Plan, the region aims to significantly enhance its role in the capital's economic development, with industrial output projected to exceed one trillion yuan [4]
北京产权交易所挂牌项目信息
Xin Lang Cai Jing· 2025-12-28 17:20
Core Viewpoint - Hunan Jiashihongli Medical Device Co., Ltd. is offering 51% equity for sale, with a listing price of 8.242236 million yuan, and the listing period is set for 20 working days [1] Group 1: Company Overview - The company operates in the medical device sector, dealing with Class I, II, and III medical devices, teaching instruments, and various consumer goods [1] - The registered address is located in the China (Hunan) Pilot Free Trade Zone, Changsha Economic Development Zone [1] Group 2: Financial Details - The equity stake is listed at a price of 8.242236 million yuan [1] - The listing period for the equity sale is 20 working days [1] Group 3: Contact Information - Contact person for inquiries is Ms. Niu, with a provided phone number for further communication [1]
2025年临空经济区可持续发展国际会议在京举办
Sou Hu Cai Jing· 2025-09-25 12:57
Core Insights - The 2025 International Conference on Sustainable Development of Airport Economic Zones opened at Daxing Airport, focusing on "Navigating the Future - International Aviation Technology Innovation and New Service Ecosystem" [1][3] Group 1: Integrated Business Licensing - The Daxing Airport Economic Zone issued its first batch of integrated business licenses, allowing new or modified business entities to have their operating locations uniformly marked as "Beijing Daxing International Airport Economic Zone" [3] - A joint "Integrated Registration Platform" was established between Beijing and Hebei, enabling cross-regional business registration and enhancing operational convenience for enterprises [3] Group 2: Major Project Signings - Eight significant projects were signed during the conference, covering industries such as aviation technology, trade logistics, and life sciences, with a total investment of 2.7 billion yuan and the construction of 136,000 square meters of industrial space [5][6] - These projects are expected to generate annual revenues of 11 billion yuan and an import-export trade volume of 10 billion yuan once operational [5] Group 3: New Service Centers and Platforms - The Daxing Airport Economic Zone launched a Clinical Urgent Product Import Service Center to streamline the import process for urgently needed medical products, enhancing service efficiency for high-level medical institutions [8] - An International Cooperation Platform for Oral Medicine was also initiated to promote global collaboration and establish the zone as a key hub for oral medicine enterprises [8] Group 4: High-Quality Development Initiatives - The conference highlighted the high-quality development of the Daxing Airport Economic Zone, emphasizing the strengthening of its functional positioning and the rapid activation of airport radiation effects [10] - Future plans include enhancing hub capabilities, building a modern aviation logistics system, and fostering a collaborative development community to break down administrative barriers [10]
北京市“两区”建设五周年成果显著 多区域协同推动高质量发展
Bei Jing Shang Bao· 2025-07-03 12:41
Core Insights - The "Two Zones" initiative in Beijing has achieved significant progress in institutional innovation, industrial development, and optimization of the business environment over the past five years, contributing to high-quality development in the capital [1][6]. Group 1: Institutional Innovation and Business Environment - Haidian District has provided valuable experiences for the national free trade zone through 98 institutional innovation cases, with 4 cases replicated nationwide and 9 cases promoted citywide, establishing a "Haidian Model" [3]. - The implementation of an "all-process online approval" model in Haidian has improved business efficiency by over 30% [3]. - Shunyi District has completed over 200 key tasks related to the "Two Zones" initiative and has formed 16 breakthrough policies and innovative models, achieving an online completion rate of over 95% for district-level approval matters [3][6]. Group 2: Industrial Development - The Yizhuang group has focused on high-end manufacturing and digital economy, achieving breakthroughs in data cross-border, biomedicine, artificial intelligence, and commercial aerospace [4]. - Changping District has developed a globally leading life science valley, with over 10 high-level research institutions and a total of 11 approved innovative drugs, contributing to a comprehensive industrial chain layout [5]. Group 3: Public Services and Talent Development - The Tianzhu Comprehensive Bonded Zone has seen a 95% year-on-year increase in the import of rare disease drugs, with an import value of 21.75 billion yuan, accounting for over 40% of the national total [6]. - Shunyi and Daxing districts are forming a synergistic development force in the biomedical field, enhancing public service systems and creating a talent innovation and entrepreneurship service system [6].